|
1TEY
NMR structure of human histone chaperone, ASF1A
Deposited 2004-05-26
|
Different construct
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–156(156 aa)
Fragment:N-TERMINAL DOMAIN (residues 1-156)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 20 mM;Pressure ambient
NMR sample composition
1mM Asf1A U-15N,13C; 20mM tris-D11; 1mM EDTA; 0.1mM DSS; 0.1 mM NaN3; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2I32
Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly
Deposited 2006-08-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–157(157 aa)
Fragment:Residues 1-157
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;298 K;CRYSTALS OF THE HUMAN ASF1AN-HIRA(425-472) COMPLEX WERE
GROWN BY HANGING DROP VAPOR DIFFUSION AT ROOM TEMPERATURE
AND WERE OBTAINED BY MIXING 2 UL OF A 0.5 MM PROTEIN
COMPLEX SOLUTION (IN 20 MM HEPES PH 7.0, 150 MM NACL AND
5 MM BETA-ME) WITH 2 UL OF RESERVOIR SOLUTION CONTAINING
1.44 M NAH2PO4 AND 0.16 M K2HPO4 AT PH 5.6, AND
EQUILIBRATING OVER 1.0 ML OF RESERVOIR SOLUTION. CRYSTALS
WERE FULLY GROWN WITHIN TWO WEEKS TO A TYPICAL SIZE OF
0.3MMX0.3MMX0.2MM, VAPOR DIFFUSION, HANGING DROP,
TEMPERATURE 298.0K
|
Resolution 2.70 Å
R-free 0.269
|
|
2I32
Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly
Deposited 2006-08-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–157(157 aa)
Fragment:Residues 1-157
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;298 K;CRYSTALS OF THE HUMAN ASF1AN-HIRA(425-472) COMPLEX WERE
GROWN BY HANGING DROP VAPOR DIFFUSION AT ROOM TEMPERATURE
AND WERE OBTAINED BY MIXING 2 UL OF A 0.5 MM PROTEIN
COMPLEX SOLUTION (IN 20 MM HEPES PH 7.0, 150 MM NACL AND
5 MM BETA-ME) WITH 2 UL OF RESERVOIR SOLUTION CONTAINING
1.44 M NAH2PO4 AND 0.16 M K2HPO4 AT PH 5.6, AND
EQUILIBRATING OVER 1.0 ML OF RESERVOIR SOLUTION. CRYSTALS
WERE FULLY GROWN WITHIN TWO WEEKS TO A TYPICAL SIZE OF
0.3MMX0.3MMX0.2MM, VAPOR DIFFUSION, HANGING DROP,
TEMPERATURE 298.0K
|
Resolution 2.70 Å
R-free 0.269
|
|
3AAD
Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction
Deposited 2009-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–155(155 aa)
Fragment:Residues 1-155
Chain D
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.65;293 K;0.1M MES, 1.1M AMMONIUM SULFATE, 0.25M LITHIUM SULFATE, pH 5.65, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.293
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain I
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain M
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain Q
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
5C3I
Crystal structure of the quaternary complex of histone H3-H4 heterodimer with chaperone ASF1 and the replicative helicase subunit MCM2
Deposited 2015-06-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain U
1–175(175 aa)
Fragment:UNP residues 1-175
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;289 K;20% PEG 3350, 2% Tacsimate,0.1 M Tris-HCl pH 8.0
|
Resolution 3.50 Å
R-free 0.253
|
|
6F0F
Crystal structure ASF1-ip2_s
Deposited 2017-11-20
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–156(156 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;298 K;Tris-HCl 0.1M pH7.5, PEG8000 5%
|
Resolution 2.00 Å
R-free 0.227
|
|
6F0G
Crystal structure ASF1-ip3
Deposited 2017-11-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–156(156 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.25M, PEG8000 7%
|
Resolution 2.30 Å
R-free 0.267
|
|
6F0G
Crystal structure ASF1-ip3
Deposited 2017-11-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–156(156 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.25M, PEG8000 7%
|
Resolution 2.30 Å
R-free 0.267
|
|
6F0H
Crystal structure ASF1-ip4
Deposited 2017-11-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
1–156(156 aa)
Chain C
1–156(156 aa)
|
Not recorded
|
SO4 SULFATE ION × 12
GOL GLYCEROL × 6
CIT CITRIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Citrate 0.1M pH 2.5, LiSO4 0.5M, PEG8000 10%
|
Resolution 1.98 Å
R-free 0.242
|
|
6ZUF
Urea-based Foldamer Inhibitor chimera C2 in complex with ASF1 Histone chaperone
Deposited 2020-07-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 3
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;100 mM Sodium Citrate pH4.2, 300 mM LiSO4, 26% PEG3350
|
Resolution 1.80 Å
R-free 0.210
|
|
6ZUF
Urea-based Foldamer Inhibitor chimera C2 in complex with ASF1 Histone chaperone
Deposited 2020-07-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 6
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;293 K;100 mM Sodium Citrate pH4.2, 300 mM LiSO4, 26% PEG3350
|
Resolution 1.80 Å
R-free 0.210
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7LO0
Structure of human ASF1a in complex with a TLK2 peptide
Deposited 2021-02-08
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
1–155(155 aa)
Fragment:Residues 1-155
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;18% PEG3350, 0.2 M of trisodium citrate, pH 5.6 and 2% Octyl-D-glucose
|
Resolution 2.71 Å
R-free 0.226
|
|
7V6Q
Crystal structure of sNASP-ASF1A-H3.1-H4 complex
Deposited 2021-08-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 4
1PE PENTAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;18% (v/v) Tacsimate, pH 5.0
11% (v/v) PEG2000MME
|
Resolution 3.00 Å
R-free 0.203
|
|
7V6Q
Crystal structure of sNASP-ASF1A-H3.1-H4 complex
Deposited 2021-08-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 2
1PE PENTAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;18% (v/v) Tacsimate, pH 5.0
11% (v/v) PEG2000MME
|
Resolution 3.00 Å
R-free 0.203
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8BV1
Peptide inhibitor P4 in complex with ASF1 histone chaperone
Deposited 2022-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290.15 K;0.1 M Tris pH 8.5
30% (w/v) PEG 400
|
Resolution 2.83 Å
R-free 0.221
|
|
8CJ1
Urea-based foldamer inhibitor c3u_3 chimera in complex with ASF1 histone chaperone
Deposited 2023-02-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
1–156(156 aa)
Chain B
1–156(156 aa)
Chain C
1–156(156 aa)
Chain D
1–156(156 aa)
Chain E
1–156(156 aa)
Chain F
1–156(156 aa)
Chain G
1–156(156 aa)
Chain H
1–156(156 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;290.15 K;0.1 M MES pH 6.5
40% (w/v) PEG 200
|
Resolution 2.56 Å
R-free 0.280
|
|
8CJ2
Urea-based foldamer inhibitor c3u_5 chimera in complex with ASF1 histone chaperone
Deposited 2023-02-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–156(156 aa)
Chain B
1–156(156 aa)
Chain C
1–156(156 aa)
Chain D
1–156(156 aa)
|
Not recorded
|
GOL GLYCEROL × 14
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;290.15 K;0.17 M ammonium sulfate
0.085 M NaOAc pH 4.6
25.5% PEG 2000 MME
15% (v/v) glycerol
|
Resolution 2.13 Å
R-free 0.215
|
|
8CJ3
Urea-based foldamer inhibitor c3u_7 chimera in complex with ASF1 histone chaperone
Deposited 2023-02-11
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–156(156 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;290.15 K;0.2 M potassium fluoride
20% (w/v) PEG 3350
|
Resolution 3.00 Å
R-free 0.217
|
|
8Z50
Crystal structure of the ASF1-H3T-H4 complex
Deposited 2024-04-18
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–173(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;1.0 M Lithium chloride, 0.1 M MES pH 6.0, 10% PEG 6000
|
Resolution 2.80 Å
R-free 0.255
|
|
9CVC
CDAN1 dimer with three ASF1A
Deposited 2024-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
1–204(204 aa)
Chain D
1–204(204 aa)
Chain E
1–204(204 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
9IMZ
CODANIN-1 sequesters ASF1 by using a histone H3 mimic helix to regulate histone supply
Deposited 2024-07-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
1–172(172 aa)
Chain D
1–172(172 aa)
Chain E
1–172(172 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.75 Å
|